S&P 500

5.431,60

-0,04%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Y mAbs Therapeutics Inc (YMAB)
Y mAbs Therapeutics Inc (YMAB) Notícias

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:YMAB

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/06/2024	22:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
13/06/2024	17:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
10/06/2024	17:59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
07/06/2024	08:05	GlobeNewswire Inc.	Y-mAbs Announces Preclinical GD2-SADA Data to be Presented at 2024 SNMMI Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
05/06/2024	08:05	GlobeNewswire Inc.	Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer	NASDAQ:YMAB	Y mAbs Therapeutics Inc
01/06/2024	09:15	GlobeNewswire Inc.	Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
01/06/2024	09:05	GlobeNewswire Inc.	Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
07/05/2024	17:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:YMAB	Y mAbs Therapeutics Inc
07/05/2024	17:05	GlobeNewswire Inc.	Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
26/04/2024	08:05	GlobeNewswire Inc.	Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024	NASDAQ:YMAB	Y mAbs Therapeutics Inc
25/04/2024	17:05	GlobeNewswire Inc.	Y-mAbs to Present at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
14/03/2024	10:05	GlobeNewswire Inc.	Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer	NASDAQ:YMAB	Y mAbs Therapeutics Inc
04/03/2024	09:30	GlobeNewswire Inc.	Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors	NASDAQ:YMAB	Y mAbs Therapeutics Inc
29/02/2024	19:04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:YMAB	Y mAbs Therapeutics Inc
29/02/2024	18:05	GlobeNewswire Inc.	Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
16/02/2024	09:30	GlobeNewswire Inc.	Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024	NASDAQ:YMAB	Y mAbs Therapeutics Inc
06/02/2024	17:59	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:YMAB	Y mAbs Therapeutics Inc
02/01/2024	18:05	GlobeNewswire Inc.	Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:YMAB	Y mAbs Therapeutics Inc
13/12/2023	18:05	GlobeNewswire Inc.	Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index	NASDAQ:YMAB	Y mAbs Therapeutics Inc
13/11/2023	18:05	GlobeNewswire Inc.	Y-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
08/11/2023	19:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
31/10/2023	08:05	GlobeNewswire Inc.	Y-mAbs to Announce Third Quarter 2023 Financial and Operating Results on November 13, 2023	NASDAQ:YMAB	Y mAbs Therapeutics Inc
18/10/2023	17:05	GlobeNewswire Inc.	Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director	NASDAQ:YMAB	Y mAbs Therapeutics Inc
17/10/2023	19:01	Dow Jones News	Y-mAbs Therapeutics New Drug Application Gets FDA Clearance	NASDAQ:YMAB	Y mAbs Therapeutics Inc
17/10/2023	17:05	GlobeNewswire Inc.	Y-mAbs Therapeutics Announces U.S. FDA Clearance of Investigational New Drug Application for CD38-SADA	NASDAQ:YMAB	Y mAbs Therapeutics Inc
16/10/2023	17:05	GlobeNewswire Inc.	Y-mAbs Announces Publication in Cancers	NASDAQ:YMAB	Y mAbs Therapeutics Inc
21/09/2023	17:05	GlobeNewswire Inc.	Y-mAbs Announces Data to be Presented at the 55th Congress of the International Society of Pediatric Oncology	NASDAQ:YMAB	Y mAbs Therapeutics Inc
06/09/2023	17:05	GlobeNewswire Inc.	Y-mAbs to Participate at Upcoming Investor Conferences in September	NASDAQ:YMAB	Y mAbs Therapeutics Inc
10/08/2023	17:05	GlobeNewswire Inc.	Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
02/08/2023	17:05	GlobeNewswire Inc.	Y-mAbs to Participate at Upcoming Investor Conferences	NASDAQ:YMAB	Y mAbs Therapeutics Inc